Titanium Platelet-rich Fibrin in Sinus Floor Elevation Through Flapless Transcrestal Approach

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-15

Study Completion Date

2023-02-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dental implant therapy in the posterior maxilla may be difficult owing to limited bone height after dental extraction with sinus pneumatization. Several approaches for sinus floor elevation have been documented, and hence flapless transcrestal sinus floor elevation is minimally invasive technique which is used in moderately defected maxilla.

Aim of the study: to evaluate both clinical and radiographic outcomes in sinus floor elevation following dental implant placement using flapless transcrestal sinus lift approach with Titanium platelet rich fibrin (TPRF) as a sole sinus graft material compared to Platelet rich fibrin (PRF).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Titanium Prepared Platelet-rich Fibrin in Bone Regeneration in Lateral Window Maxillary Sinus Augmentation

NCT06135077

Sinus Lifting

COMPLETED NA

Fibrin Glue Versus Titanium Platelet-rich Fibrin in Lateral Sinus Lifting

NCT05831267

Sinus Floor Augmentation Graftless Sinus Elevation

COMPLETED NA

PRF vs. Graftless Sinus Lift With Implant Placement

NCT07090694

Maxillary Sinus Floor Augmentation Alveolar Bone Loss Atrophy +2 more

ENROLLING_BY_INVITATION PHASE1

Sinus Lift Using PTFE Titanium Reinforced Membrane

NCT05044260

Sinus Lift

UNKNOWN NA

Biphasic Material With PRF in Lateral Sinus Floor Augmentation

NCT06071416

Maxillary Sinus Disease

NOT_YET_RECRUITING PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sinus Floor Elevation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Group Type EXPERIMENTAL

Flapless transcrestal sinus lift approach with TPRF

Intervention Type OTHER

Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the TPRF as a sole grafting material.

Control gorup

Group Type ACTIVE_COMPARATOR

Flapless transcrestal sinus lift approach with PRF

Intervention Type OTHER

Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the PRF as a sole grafting material.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Flapless transcrestal sinus lift approach with TPRF

Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the TPRF as a sole grafting material.

Intervention Type OTHER

Flapless transcrestal sinus lift approach with PRF

Including 8 patients who will be treated by flapless transcrestal sinus floor elevation using the PRF as a sole grafting material.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient seeking replacement of a missed maxillary posterior teeth by a delayed dental implant procedure.
* Residual bone height is (4-7) mm measured from crestal bone to sinus floor.
* Good oral hygiene

Exclusion Criteria

* Uncontrolled Diabetes.
* Coagulation disorders.
* Immunological disorders.
* Previous radiation of the head and neck region.
* Abnormal bone physiology.
* Therapy with Bisphosphonates.

Minimum Eligible Age

25 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No